Onto-phylogenetic prerequisites for development of chronic cystitis in women

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Urinary tract infections (UTIs) are among the most common bacterial infections. At the request “cystitis”, there are 12,067 publications in the RSCI system (e.library) as of 10/08/2023 and 16,332 articles were screened in the Pubmed. This is evidence that the problem of cystitis is far from being resolved.

Material and methods. A total of 425 patients with bacterial vaginosis and 77 women with chronic recurrent cystitis were included in the study. In all patients, the vaginal biocenosis was assessed through molecular genetic testing. The examination included filling out the Russian version of the Acute Cystitis Symptom Score (ACSS), urinalysis, and urine culture. In addition, local microcirculation was measured using laser Doppler flowmetry (LDF). After examination, patients were prescribed basic therapy and randomly assigned to one of three groups. In a control group (n=17), only basic therapy, consisting of fosfomycin 3.0 once at night + furagin 100 mg after meals 3 times a day for 5 days was prescribed. In the main group 1, 29 women received basic therapy plus Superlymph® suppositories 10 units 2 times a day vaginally for 10 days. In the main group 2, 31 patients received basic therapy plus suppositories Superlymph® 10 units (rectally in the morning) and Acylact Duo (vaginally in the evening) for 10 days.

Results. Among 425 patients with bacterial vaginosis, 78 (18.3%) complained of various urinary disorders, but only 21 women (4.9% of those with vaginal dysbiosis and 26.9% with dysuria) had a diagnosis of cystitis. In all cases, it was an exacerbation of a chronic disease. Among 77 patients with chronic cystitis, normal vaginal flora was initially present in 32 patients (41.6%), and bacterial vaginosis was found in 45 (58.4%) cases.

After therapy, positive results were noted in patients of all groups. Complete eradication of the pathogen occurred in 15 women (88.2%) who received only basic therapy; in the main groups 1 and 2, uropathogens were not detected in 27 (93.1%) and 28 (90.3%) cases, respectively. In the control group, the proportion of patients with normal vaginal flora remained virtually unchanged (41.2% [n=7] vs. 47.1% [n=8]). In the main group 1, the proportion of patients with normal vaginal flora almost doubled: from 41.4% (n=12) to 79.3% (n=23). In main group 2, restoration of vaginal flora was noted in 87.1% of cases.

Conclusion. According to our data, only 4.9% of patients with bacterial vaginosis were diagnosed with chronic cystitis, however, 58.4% of patients with chronic cystitis had vaginal dysbiosis. The use of a complex of antimicrobial peptides and cytokines has significantly increased the bidirectional effect of therapy. Suppositories Superlymph in a combination with vaginal use of Acylact Duo allow to obtain the best results.

Full Text

Restricted Access

About the authors

E. V. Kulchavenya

Novosibirsk State Medical University of Ministry of Health of Russia; Privolzhsky Research Medical University of the Ministry of Health of the Russia; Medical Center «Avicenna»

Author for correspondence.
Email: urotub@yandex.ru

Ph.D., MD, professor, professor at Department of Phthisiopulmonology, professor at the Department of Urology named after E.V. Shakhov, Scientific Chief

Russian Federation, Novosibirsk; Nizhny Novgorod; Novosibirsk

L. S. Treyvish

Medical Center «Avicenna»

Email: urotub@yandex.ru

Head of the Gynecologic Department

Russian Federation, Novosibirsk

Е. V. Telina

Medical Center «Avicenna»

Email: urology-avicenna@mail.ru

obstetrician-gynecologist, General Director

Russian Federation, Novosibirsk

А. Yu. Tsukanov

Omsk State Medical University of the Ministry of Health of Russian Federation

Email: urotub@yandex.ru

Ph.D., MD, professor, Head of Department of Surgical diseases and Urology

Russian Federation, Omsk

А. I. Neymark

Altai State Medical University of the Ministry of Health of Russia

Email: urologagmu@mail.ru

Ph.D., MD, professor, Head of the Department of Urology and Andrology with a course of Specialized Surgery

Russian Federation, Barnaul

A. B. Neymark

Altai State Medical University of the Ministry of Health of Russia

Email: urologagmu@mail.ru

student

Russian Federation, Barnaul

D. P. Kholtobin

Medical Center «Avicenna»

Email: urotub@yandex.ru

Ph.D., MD, Head of the Urologic Department

Russian Federation, Novosibirsk

M. V. Razdorskaya

Private Clinical Hospital «Russian Railways – Medicine»

Email: urotub@yandex.ru

urologist at the Department of Urology

Russian Federation, Barnaul

References

  1. Abell-King C., Costas A., Duggin I.G., Söderström B. Bacterial filamentation during urinary tract infections. PLoS Pathog. 2022;18(12):e1010950. doi: 10.1371/journal.ppat.1010950.
  2. Mann R., Mediati D.G., Duggin I.G., Harry E.J., Bottomley A.L. Metabolic Adaptations of Uropathogenic E. coli in the Urinary Tract. Front Cell Infect Microbiol. 2017;7:241. doi: 10.3389/fcimb.2017.00241.
  3. Cai T., Tamanini I., Collini L., Brugnolli A., Migno S., Mereu L., Tateo S., Pilatz A., Rizzo M., Liguori G., Bonkat G., Wagenlehner F.M.E, Bjerklund Johansen T.E. Management of Recurrent Cystitis in Women: When Prompt Identification of Risk Factors Might Make a Difference. Eur Urol Focus. 2022;(5):1476–1482. doi: 10.1016/j.euf.2022.01.014.
  4. Kulchavenya E.V., Neymark A.I. Cystitis: issues of diagnosis and treatment. St. Petersburg: Scythia-print; M.: Prof. medpress, 2023. 296 p. ISBN 978-5-98620-665-3. Russian (Кульчавеня Е.В., Неймарк А.И. Цистит: вопросы диагностики и лечения. СПб.: Скифия-принт; М.: Профмедпресс, 2023. 296 с. ISBN 978-5-98620-665-3).
  5. Johansen T.E.B., Zahl P., Baco, E. Bartoletti R., Bonkat G., Bruyere F., Cai T., Cek M., Kulchavenya E. et al. Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry. World J Urol. 2020;38:17–26. doi: 10.1007/s00345-019-02837-0.
  6. Longhi C., Comanducci A., Riccioli A., Ziparo E., Marazzato M., Aleandri M., Conte A.L., Lepanto M.S., Goldoni P., Conte M.P. Features of uropathogenic Escherichia coli able to invade a prostate cell line. New Microbiol. 2016;39(2):146–149.
  7. Owrangi B., Masters N., Kuballa A., O’Dea C., Vollmerhausen T.L., Katouli M. Invasion and translocation of uropathogenic Escherichia coli isolated from urosepsis and patients with community-acquired urinary tract infection. Eur J Clin Microbiol Infect Dis. 2018;37(5):833–839. doi: 10.1007/s10096-017-3176-4.
  8. Gilbert N.M., O’Brien V.P., Lewis A.L. Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease. PLoS Pathog. 2017;13(3):e1006238. doi: 10.1371/journal.ppat.1006238.
  9. Kogan M.I., Naboka Y.L., Ibishev H.S., Gudima I.A. Non-sterility of urine of a healthy person is a new paradigm in medicine. Urology. 2014;5:48–52. Russian (Коган М.И., Набока Ю.Л., Ибишев Х.С., Гудима И.А.. Нестерильность мочи здорового человека – новая парадигма в медицине. Урология. 2014;5:48–52).
  10. Hugenholtz F., van der Veer C., Terpstra M.L., Borgdorff H., van Houdt R., Bruisten S., Geerlings S.E., van de Wijgert J.H.H.M. Urine and vaginal microbiota compositions of postmenopausal and premenopausal women differ regardless of recurrent urinary tract infection and renal transplant status. Sci Rep. 2022;12(1):2698. doi: 10.1038/s41598-022-06646-1.
  11. Vaginal microbiota: possibilities of correction of dysbiotic conditions: a textbook / edited by Professor of the Department of Microbiology, Virology and Immunology, MD, Professor E.S. Voroshilina. Yekaterinburg: UMMC, 2022, 160 p. Russian (Микробиота влагалища: возможности коррекции дисбиотических состояний: учебное пособие/под редакцией профессора кафедры микробиологии, вирусологии и иммунологии, д.м.н., профессора Е. С. Ворошилиной. Екатеринбург: УГМУ, 2022, 160 с.).
  12. Gyaurgiev T.A., Kuzmenko A.V., Kuzmenko V.V. The efficiency of various cytokine therapy regimens in the complex treatment of men with chronic abacterial prostatitis. Urologiia. 2023;1:12–19 Doi: https: //dx.doi.org/10.18565/urology.2023.1.12–19. Russian (Гяургиев Т.А., Кузьменко А.В., Кузьменко В.В. Эффективность различных режимов цитокинотерапии в комплексном лечении мужчин с хроническим абактериальным простатитом. Урология. 2023;1:12–19 Doi: https: //dx.doi.org/10.18565/urology.2023.1.12-19).
  13. Berkovich O.A. Antiviral effects of a complex of natural cytokines (Superlimf drug) on a model of herpesvirus infection in vitro. The author’s abstract. Dissertation ... PhD, Moscow, 2005. Russian (Баркевич О.А. Противовирусные эффекты комплекса природных цитокинов (препарат Суперлимф) на модели герпесвирусной инфекции in vitro. Автореф. дисс. … к.м.н., Москва, 2005).
  14. Viryasov A.V. The role of the cytokine complex (Superlimf) in the treatment of patients with chronic bacterial and abacterial prostatitis. The author’s abstract. Dissertation ...Candidate of Medical Sciences, Moscow, 2007. Russian (Вирясов А.В. Роль комплекса цитокинов (Суперлимф) в лечении больных хроническим бактериальным и абактериальным простатитом. Автореф. дисс. …к.м.н., Москва, 2007).
  15. Khryanin A.A., Reshetnikov O.V. Combined therapy of chronic bacterial prostatitis. Urologiia. 2016;3(suppl.):91–96. Russian (Хрянин А.А., Решетников О.В. Комбинированная терапия хронического бактериального простатита. Урология. 2016;3(suppl.):91–96).
  16. Dhillon S. Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections. Drugs. 2018;78(12):1259–1270. doi: 10.1007/s40265-018-0966-7. Erratum in: Drugs. 2018 Sep;78(13):1383.
  17. Harmanli O.H., Cheng G.Y., Nyirjesy P., Chatwani A., Gaughan J.P. Urinary tract infections in women with bacterial vaginosis. Obstet Gynecol. 2000 May;95(5):710–712. doi: 10.1016/s0029-7844(99)00632-8.
  18. Kosova I.V., Barseghyan V.A., Sinyakova L.A., Lukyanov I.V., Kolbasov D.N. Vaginal dysbiosis as a factor in the development of recurrent lower urinary tract infections. Bulletin of Urology. 2023;11(1):34–41. doi: 10.21886/2308-64. Russian (Косова И.В., Барсегян В.А., Синякова Л.А., Лукьянов И.В., Колбасов Д.Н. Дисбиоз влагалища как фактор развития рецидивирующих инфекций нижних мочевых путей. Вестник урологии. 2023;11(1):34–41. doi: 10.21886/2308-64).
  19. Ковалёва Ю.С., Абдалхалим М.А.М., Неймарк А.И., Неймарк Б.А. Эффективность терапии хронического цистита у женщин на фоне урогенитальной инфекции. Вестник СурГУ. Медицина. 2022;1(51):36–41.
  20. Sumati A.H., Saritha N.K. Association of urinary tract infection in women with bacterial vaginosis. J Glob Infect Dis. 2009l;1(2):151–152. doi: 10.4103/0974-777X.56254.
  21. Handa V.L., Brotman R.M., Ravel J. et al. Does Bacterial Vaginosis Contribute to Urinary Tract Infection? Curr Infect Dis Rep. 2023;25:17–27. https://doi.org/10.1007/s11908-022-00795-0
  22. Gilbert N.M., O’Brien V.P., Lewis A.L. Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease. PLoS Pathog. 2017;13(3):e1006238. doi: 10.1371/journal.ppat.1006238.
  23. Kulchavenya E., Kholtobin D., Shevchenko S. Challenges in urogenital tuberculosis. World Journal of Urology. World J Urol. 2020;38:89–94.doi: 10.1007/s00345-019-02767-x.
  24. Sadahira T., Wada K., Araki M., Mitsuhata R., Yamamoto M., Maruyama Y., Iwata T., Watanabe M., Watanabe T., Kariyama R., Nasu Y., Ishii A. Efficacy of Lactobacillus vaginal suppositories for the prevention of recurrent cystitis: A phase II clinical trial. Int J Urol. 2021;28(10):1026–1031. doi: 10.1111/iju.14636.
  25. Wada K., Uehara S., Ishii A., Sadahira T., Yamamoto M., Mitsuhata R., Takamoto A., Araki M., Kobayashi Y., Watanabe M., Watanabe T., Hotta K., Nasu Y. A Phase II Clinical Trial Evaluating the Preventive Effectiveness of Lactobacillus Vaginal Suppositories in Patients with Recurrent Cystitis. Acta Med Okayama. 2016;70(4):299–302. doi: 10.18926/AMO/54508.
  26. Apolikhina I.A., Malyshkina D.A. Chronic recurrent cystitis: modern approaches to treatment. Medical opponent. 2020;2(10):30–34. Russian (Аполихина И.А., Малышкина Д.А. Хронические рецидивирующие циститы: современные подходы к лечению. Медицинский оппонент. 2020;2(10):30–34).

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1.

Download (84KB)
3. Fig. 2.

Download (100KB)
4. Fig. 3.

Download (101KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies